Stevanato Group (NYSE:STVN) Director Purchases €274,400.00 in Stock

Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) Director William Federici acquired 20,000 shares of the firm’s stock in a transaction that occurred on Monday, November 9th. The stock was acquired at an average price of €13.72 per share, for a total transaction of €274,400.00. Following the completion of the acquisition, the director directly owned 46,991 shares of the company’s stock, valued at €644,716.52. The trade was a 74.10% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

Stevanato Group Trading Up 3.0%

Stevanato Group stock traded up €0.42 during mid-day trading on Thursday, hitting €14.33. The company’s stock had a trading volume of 879,105 shares, compared to its average volume of 563,473. The firm has a market capitalization of $4.34 billion, a PE ratio of 24.70, a price-to-earnings-growth ratio of 1.40 and a beta of 0.80. Stevanato Group S.p.A. has a 1 year low of €12.05 and a 1 year high of €24.01. The company has a current ratio of 1.73, a quick ratio of 1.19 and a debt-to-equity ratio of 0.22. The stock’s fifty day moving average is €19.36 and its two-hundred day moving average is €17.93.

Stevanato Group (NYSE:STVN – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing analysts’ consensus estimates of €0.17 by (€0.01). Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. The business had revenue of €326.06 million during the quarter. On average, analysts anticipate that Stevanato Group S.p.A. will post 0.67 EPS for the current year.

Hedge Funds Weigh In On Stevanato Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. GW&K Investment Management LLC lifted its position in shares of Stevanato Group by 118.3% during the third quarter. GW&K Investment Management LLC now owns 6,086 shares of the company’s stock worth $128,000 after purchasing an additional 3,298 shares in the last quarter. Ieq Capital LLC purchased a new stake in Stevanato Group during the 3rd quarter worth approximately $292,000. Montanaro Asset Management Ltd lifted its holdings in Stevanato Group by 42.4% during the 3rd quarter. Montanaro Asset Management Ltd now owns 200,000 shares of the company’s stock worth $4,196,000 after buying an additional 59,541 shares in the last quarter. Russell Investments Group Ltd. lifted its holdings in Stevanato Group by 2.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 274,637 shares of the company’s stock worth $5,762,000 after buying an additional 6,542 shares in the last quarter. Finally, Riverbridge Partners LLC lifted its holdings in Stevanato Group by 4.2% during the 3rd quarter. Riverbridge Partners LLC now owns 625,914 shares of the company’s stock worth $13,132,000 after buying an additional 25,400 shares in the last quarter.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on STVN shares. Citigroup reduced their price objective on shares of Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. William Blair downgraded shares of Stevanato Group from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Deutsche Bank initiated coverage on shares of Stevanato Group in a report on Wednesday, October 7th. They issued a “hold” rating on the stock. Weiss Ratings raised shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Finally, UBS Group cut their target price on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 4th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Stevanato Group presently has an average rating of “Moderate Buy”.

Check Out Our Latest Research Report on Stevanato Group

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

Recommended Stories

Insider Buying and Selling by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.